| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2014PLoSO...9j5971F |
| P356 | DOI | 10.1371/JOURNAL.PONE.0105971 |
| P932 | PMC publication ID | 4141859 |
| P698 | PubMed publication ID | 25148524 |
| P5875 | ResearchGate publication ID | 264990177 |
| P50 | author | Georges Vassaux | Q39997171 |
| Sue Brown | Q43179657 | ||
| P2093 | author name string | Cesare M Terracciano | |
| Marta Fernandez-Fuente | |||
| Richard J Piercy | |||
| Pilar Martin-Duque | |||
| P2860 | cites work | A simplified system for generating recombinant adenoviruses | Q24682328 |
| Enhanced resistance to fatigue and altered calcium handling properties of sarcalumenin knockout mice | Q28509838 | ||
| Identification of four novel mutations in the C-terminal membrane spanning domain of the ryanodine receptor 1: association with central core disease and alteration of calcium homeostasis | Q29871452 | ||
| A duchenne muscular dystrophy gene hot spot mutation in dystrophin-deficient cavalier king charles spaniels is amenable to exon 51 skipping | Q33523810 | ||
| Genetics and pathogenesis of malignant hyperthermia | Q33789806 | ||
| RyR1-mediated Ca2+ leak and Ca2+ entry determine resting intracellular Ca2+ in skeletal myotubes | Q33810099 | ||
| MyoD converts primary dermal fibroblasts, chondroblasts, smooth muscle, and retinal pigmented epithelial cells into striated mononucleated myoblasts and multinucleated myotubes | Q33843740 | ||
| Ryanodine receptor mutations in malignant hyperthermia and central core disease | Q33903152 | ||
| Epidemiology of exertional rhabdomyolysis susceptibility in standardbred horses reveals associated risk factors and underlying enhanced performance | Q33996146 | ||
| Myoblasts generated by lentiviral mediated MyoD transduction of myotonic dystrophy type 1 (DM1) fibroblasts can be used for assays of therapeutic molecules | Q34073069 | ||
| Autosomal dominant canine malignant hyperthermia is caused by a mutation in the gene encoding the skeletal muscle calcium release channel (RYR1). | Q34092847 | ||
| Anaesthetic deaths in a family | Q34251990 | ||
| Activation of muscle-specific genes in pigment, nerve, fat, liver, and fibroblast cell lines by forced expression of MyoD. | Q34290920 | ||
| Use of thapsigargin to study Ca2+ homeostasis in cardiac cells | Q34399135 | ||
| Identification of a Mutation in Porcine Ryanodine Receptor Associated with Malignant Hyperthermia | Q34795568 | ||
| Orthograde dihydropyridine receptor signal regulates ryanodine receptor passive leak | Q34880821 | ||
| Excitation--contraction uncoupling by a human central core disease mutation in the ryanodine receptor | Q35060776 | ||
| Epigenetic allele silencing unveils recessive RYR1 mutations in core myopathies | Q35221453 | ||
| Effects of tetracaine on voltage-activated calcium sparks in frog intact skeletal muscle fibers | Q36295622 | ||
| The role of Ca2+ in muscle cell damage | Q36420086 | ||
| Effects of perchlorate on the molecules of excitation-contraction coupling of skeletal and cardiac muscle | Q36435118 | ||
| A mutation in the transmembrane/luminal domain of the ryanodine receptor is associated with abnormal Ca2+ release channel function and severe central core disease | Q36460971 | ||
| Dantrolene-induced inhibition of skeletal L-type Ca2+ current requires RyR1 expression | Q36665389 | ||
| The skeletal L-type Ca(2+) current is a major contributor to excitation-coupled Ca(2+) entry | Q37023260 | ||
| SERCA pumps and human diseases. | Q37056443 | ||
| A recessive ryanodine receptor 1 mutation in a CCD patient increases channel activity | Q37142856 | ||
| Effects of tetracaine on sarcoplasmic calcium release in mammalian skeletal muscle fibres. | Q51471892 | ||
| Dual effects of tetracaine on spontaneous calcium release in rat ventricular myocytes. | Q51544236 | ||
| Differential effects of ryanodine and tetracaine on charge movement and calcium transients in frog skeletal muscle | Q51722203 | ||
| Intracellular ionized calcium concentration in muscles from humans with malignant hyperthermia. | Q51825849 | ||
| RyR1 deficiency in congenital myopathies disrupts excitation-contraction coupling. | Q52639740 | ||
| Pale, soft exudative pork, porcine stress syndrome and malignant hyperpyrexia--an identity? | Q52735184 | ||
| Clinical and genetic findings in a large cohort of patients with ryanodine receptor 1 gene-associated myopathies | Q57334263 | ||
| Localization of the malignant hyperthermia susceptibility locus to human chromosome 19q12-q13.2. | Q68873777 | ||
| Pharmacokinetics of dantrolene sodium in horses | Q69403368 | ||
| [Ca2+]i in muscles of malignant hyperthermia susceptible pigs determined in vivo with Ca2+ selective microelectrodes | Q70020725 | ||
| Ratio of dihydropyridine to ryanodine receptors in mammalian and frog twitch muscles in relation to the mechanical hypothesis of excitation-contraction coupling | Q72704089 | ||
| Epidemiologic analysis of factors influencing exertional rhabdomyolysis in Thoroughbreds | Q73326857 | ||
| Methods for animal satellite cell culture under a variety of conditions | Q73391179 | ||
| In vitro contractile responses and contracture testing of skeletal muscle from Quarter Horses with exertional rhabdomyolysis | Q77905616 | ||
| Exclusion of linkage of the RYR1, CACNA1S, and ATP2A1 genes to recurrent exertional rhabdomyolysis in Thoroughbreds | Q80041563 | ||
| Prevalence and demographic characteristics of exertional rhabdomyolysis in horses in Australia | Q81082626 | ||
| Incidence and risk factors associated with exertional rhabdomyolysis syndrome in National Hunt racehorses in Great Britain | Q81840578 | ||
| Effect of feed restriction on plasma dantrolene concentrations in horses | Q82358920 | ||
| High efficiency myogenic conversion of human fibroblasts by adenoviral vector-mediated MyoD gene transfer. An alternative strategy for ex vivo gene therapy of primary myopathies | Q37381930 | ||
| Ca2+ dysregulation in Ryr1(I4895T/wt) mice causes congenital myopathy with progressive formation of minicores, cores, and nemaline rods | Q37458493 | ||
| Conformational activation of Ca2+ entry by depolarization of skeletal myotubes | Q37595562 | ||
| Core myopathies | Q37968743 | ||
| Brody syndrome: a clinically heterogeneous entity distinct from Brody disease: a review of literature and a cross-sectional clinical study in 17 patients | Q38019238 | ||
| Standardization of the caffeine halothane muscle contracture test. North American Malignant Hyperthermia Group | Q38693338 | ||
| Elevated resting [Ca(2+)](i) in myotubes expressing malignant hyperthermia RyR1 cDNAs is partially restored by modulation of passive calcium leak from the SR. | Q40191570 | ||
| Characterization of recessive RYR1 mutations in core myopathies | Q40238382 | ||
| Myocyte differentiation generates nuclear invaginations traversed by myofibrils associating with sarcomeric protein mRNAs | Q40486212 | ||
| The effects of pentobarbital on 2,4-dinitrophenol induced malignant hyperthermia during halothane general anesthesia in dogs | Q40923434 | ||
| Malignant hyperthermia: excitation-contraction coupling, Ca2+ release channel, and cell Ca2+ regulation defects | Q40980921 | ||
| Measurement of resting cytosolic Ca2+ concentrations and Ca2+ store size in HEK-293 cells transfected with malignant hyperthermia or central core disease mutant Ca2+ release channels. | Q40984666 | ||
| Adenovirus-mediated expression of myogenic differentiation factor 1 (MyoD) in equine and human dermal fibroblasts enables their conversion to caffeine-sensitive myotubes | Q42248848 | ||
| Store-operated Ca2+ entry modulates sarcoplasmic reticulum Ca2+ loading in neonatal rabbit cardiac ventricular myocytes. | Q42678340 | ||
| Assessment of the transformation of equine skin-derived fibroblasts to multinucleated skeletal myotubes following lentiviral-induced expression of equine myogenic differentiation 1. | Q42805722 | ||
| Recognizing and managing a malignant hyperthermia crisis: guidelines from the European Malignant Hyperthermia Group | Q42908824 | ||
| T-tubule depolarization-induced SR Ca2+ release is controlled by dihydropyridine receptor- and Ca(2+)-dependent mechanisms in cell homogenates from rabbit skeletal muscle | Q42976969 | ||
| A quantitative technique for growing human adult skeletal muscle in culture starting from mononucleated cells | Q43878653 | ||
| Effect of oral administration of dantrolene sodium on serum creatine kinase activity after exercise in horses with recurrent exertional rhabdomyolysis | Q44726032 | ||
| Effect of ryanodine receptor mutations on interleukin-6 release and intracellular calcium homeostasis in human myotubes from malignant hyperthermia-susceptible individuals and patients affected by central core disease | Q45010236 | ||
| Association of a mutation in the ryanodine receptor 1 gene with equine malignant hyperthermia | Q45023074 | ||
| Pharmacokinetics and metabolism of dantrolene in horses | Q45826305 | ||
| Mutations in RYR1 are a common cause of exertional myalgia and rhabdomyolysis. | Q45982130 | ||
| Identification of a missense mutation in the bovine ATP2A1 gene in congenital pseudomyotonia of Chianina cattle: an animal model of human Brody disease. | Q46023528 | ||
| Three independent mechanisms contribute to tetracaine inhibition of cardiac calcium release channels | Q48259475 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | e105971 | |
| P577 | publication date | 2014-01-01 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Calcium homeostasis in myogenic differentiation factor 1 (MyoD)-transformed, virally-transduced, skin-derived equine myotubes | |
| P478 | volume | 9 |
Search more.